GLP-1 drugs achieve some of these effects by directly affecting the brain’s cravings for food, and that might also extend to ...

David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...

Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 ...

The diabetes and weight loss drugs are “not cost-effective at their current prices, and are largely unavailable to people with lower incomes,” the report said.

Embla today announced results from a 64-week real-world study presented at the European Congress on Obesity, tracking nearly 2,700 adults in a digital GLP-1 treatment program. The study found that ...

New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity ...

Prescription drug spending in the United States rose by 10.2% last year, thanks in part to the popularity of GLP weight-loss ...

Biocon Group chairperson Kiran Mazumdar-Shaw predicts FY26 as a growth year, fueled by biosimilars, generics, and research ...

Former FDA Commissioner Dr. David Kessler and Dr. Jon LaPook join CBS Mornings to discuss the science behind weight loss ...

Weight-loss and diabetes drugs dominated pharmaceutical spending last year, according to a new report by the American Society ...